Gainplan LLC Pfizer Inc Transaction History

Gainplan LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $195,379 - $231,658	4,199 New	4,199 $213,000
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $328,988 - $407,657	-7,191 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$41.32 - $61.25 $59,955 - $88,873	1,451 Added 25.28%	7,191 $425,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $225,295 - $289,410	5,740 New	5,740 $242,000
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $291,732 - $330,484	-8,124 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $67,448 - $76,068	2,014 Added 32.96%	8,124 $301,000
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $204,501 - $260,041	6,110 New	6,110 $225,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Gainplan LLC, based on Form 13F filings with the SEC.

Stay updated on Gainplan LLC with notifications on news.